Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban Level Among Thai Elderly Patients With Nonvalvular Atrial Fibrillation (Real-world Study)
TCTR20251119008Recruiting
- Sponsor
- Silpakorn University
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of apixaban in Atrial fibrillation (AFib), sponsored by Silpakorn University. Primary endpoint: Apixaban plasma level. Started Nov 2025; status: recruiting.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20251119008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251119008.